The House of Commons rebuked the president of the Canadian Public Health Agency for not turning over sensitive information pertaining to the dismissal of government scientists from the National Microbiology Laboratory.
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.
Genetically modified bacteria that don’t survive unless given an unnatural amino acid could serve as a new control measure to protect wild organisms and ecosystems against accidental release.
After a string of breaches involving anthrax, Ebola, and bird flu, the US Centers for Disease Control and Prevention has reportedly replaced the director of its Division of Select Agents and Toxins.
As the world inches closer to polio eradication, laboratories studying the virus will have to bolster biosafety standards. Eventually, most will need to stop working with the pathogen entirely.
The Defense Department reports that live samples of the deadly bacterium may have been accidentally shipped to more than 50 labs in the U.S. and abroad.
In the wake of numerous safety breaches at the federal agency, a new report finds US Centers for Disease Control and Prevention oversight “inconsistent and insufficient at multiple levels.”